From: ZEB1-AS1 initiates a miRNA-mediated ceRNA network to facilitate gastric cancer progression
Variable | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
HR (95% CI) | P-value | HR (95% CI) | P-value | |
Age (≥ 60) | 1.004 (0.985–1.023) | 0.697 |  |  |
Gender (male) | 1.069 (0.649–1.762) | 0.793 |  |  |
Differentiation (poor) | 1.207 (0.735–1.980) | 0.458 |  |  |
Lymph node metastasis (yes) | 1.382 (1.017–2.783) | 0.276 |  |  |
Tumor size (> 5 cm) | 1.303 (1.064–3.886) | 0.375 |  |  |
Invasion depth (T3–T4) | 2.639 (1.561–4.459) | 0.015* | 2.235 (1.139–4.132) | 0.111 |
TNM stage (III–IV) | 5.232 (2.943–9.303) | 0.001* | 3.929 (2.115–7.299) | 0.037* |
miR-143-3p (high) | 0.251 (0.039–2.176) | 0.025* | 0.491 (1.014–4.858) | 0.041* |
ZEB1-AS1 (high) | 3.740 (1.636–4.589) | 0.003* | 2.786 (1.216–6.153) | 0.011* |